|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61K 45/06 |
| (11) | Number of the document | 2230254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10160260.5 |
| Date of filing the European patent application | 2004-11-19 | |
| (97) | Date of publication of the European application | 2010-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 524732 P | 2003-11-21 | US |
| (72) |
Wang, Yan, US
Bishop, Walter Robert, US
Pachter, Jonathan A, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | Anti-IGFR1 antibody therapeutic combinations |
| Anti-IGFR1 antibody therapeutic combinations |